CIK 0001534133 · Non-accelerated filer<br>Smaller reporting company
CalciMedica, Inc.
Sign in to watch- Ticker
- CALC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452120079
- Phone
- 858-952-5500
- Business address
- 505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA, 92037
- Former names
- CalciMedica, Inc. /DE/, GRAYBUG VISION, INC., GRAYBUG, Inc., GRAYBUG LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-21 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +3,508 | $2.79 | $10K | 60,907 |
| 2025-08-20 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +2,000 | $2.72 | $5K | 57,399 |
| 2025-08-20 | Roberts Eric W CHIEF BUSINESS OFFICER | Option exercise | +15,000 | $1.53 | $23K | 179,706 |
| 2025-08-20 | Roberts Eric W CHIEF BUSINESS OFFICER | Option exercise · Employee Stock Option (Right to Buy) | −15,000 | $1.53 | $23K | 57,750 |
| 2025-08-19 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +1,000 | $2.79 | $3K | 55,399 |
| 2025-08-19 | Hebbar Sudarshan Chief Medical Officer | Purchase | +9,563 | $2.82 | $27K | 61,539 |
| 2025-08-15 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +5,076 | $2.90 | $15K | 54,399 |
| 2025-08-15 | Hebbar Sudarshan Chief Medical Officer | Purchase | +4,392 | $2.79 | $12K | 51,976 |
| 2025-08-14 | Hebbar Sudarshan Chief Medical Officer | Purchase | +1,584 | $2.59 | $4K | 47,584 |
| 2025-07-28 | Stauderman Kenneth A. Chief Scientific Officer | Purchase | +1,000 | $3.96 | $4K | 12,944 |
| 2025-07-25 | Stauderman Kenneth A. Chief Scientific Officer | Sale | −1,000 | $3.65 | $4K | 0 |
| 2025-07-22 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +1,500 | $3.78 | $6K | 49,323 |
| 2025-07-21 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +1,500 | $3.37 | $5K | 47,823 |
| 2025-07-21 | Leheny A. Rachel CHIEF EXECUTIVE OFFICER | Purchase | +1,000 | $3.40 | $3K | 3,500 |
| 2025-07-18 | WILSON ROBERT N Director | Purchase | +4,500 | $2.87 | $13K | 422,029 |
| 2025-07-18 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +2,000 | $2.88 | $6K | 46,323 |
| 2025-07-14 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +6,500 | $2.43 | $16K | 44,323 |
| 2025-07-14 | Leheny A. Rachel CHIEF EXECUTIVE OFFICER | Purchase | +2,500 | $2.47 | $6K | 2,500 |
| 2025-07-09 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +5,000 | $1.60 | $8K | 37,823 |
| 2025-07-01 | Stauderman Kenneth A. Chief Scientific Officer | Purchase | +1,000 | $1.85 | $2K | 1,000 |
Page 3 of 29 · 565 trades